Thermography shouldn?t be used instead of mammography to screen for or diagnose breast cancer, according to a June 2 press release issued by the United States Food and Drug Administration (FDA). The agency made the announcement in response to claims that thermal imaging can find breast cancer earlier than mammograms.
Thermography shouldn’t be used instead of mammography to screen for or diagnose breast cancer, according to a June 2 press release issued by the United States Food and Drug Administration (FDA). The agency made the announcement in response to claims that thermal imaging can find breast cancer earlier than mammograms.
“Mammography is still the most effective screening method for detecting breast cancer in its early, most treatable stages,” says Helen Barr, MD, director of the Division of Mammography Quality and Radiation Programs at the FDA’s Center for Devices and Radiological Health. “While there is plenty of evidence that mammography is effective in breast cancer detection, there is simply no evidence that thermography can take its place.”
The FDA has cleared thermography, which shows the patterns of heat and blood flow on or near the surface of the body by infrared image, as an adjunct tool but not as a standalone method to screen for or diagnose breast cancer. Several warning letters from the agency have been sent to healthcare providers and a manufacturer who claim that thermography is an alternative to mammography.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More